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A B S T R A C T
Background: Cadmium is a toxic heavy metal that has been implicated in breast cancer etiology, albeit with
inconsistent results.
Objective: To investigate the shape of the relation between cadmium exposure and breast cancer incidence and
mortality in cohort studies.
Data sources: Following a literature search through April 14, 2020, we carried out a systematic review and dose-
response meta-analysis to investigate the shape of the relation between cadmium exposure (assessed either
through diet or urine excretion) and disease incidence and mortality.
Study eligibility criteria: For inclusion, a study had to report incidence or mortality for breast cancer according to
baseline cadmium exposure category; be a prospective cohort, case-cohort or nested case-control study with a
minimum one-year follow-up, and reporting effect estimates for all exposure categories.
Study appraisal and synthesis methods: Studies were evaluated using the ROBINS-E risk of bias tool. The effects in
humans were assessed quantitatively using one-stage dose-response meta-analysis in a random effects meta-
analytical model.
Results: We identified 10 studies eligible for inclusion in the dose-response meta-analysis, six based on cadmium
dietary intake, and four on urinary excretion levels. We found a marginal and imprecise positive relation be-
tween dietary cadmium intake and breast cancer, and no association when urinary cadmium excretion was used
for exposure assessment. Compared to no exposure, at 20 µg/day of cadmium intake the summary risk ratio was
1.12 (95% confidence interval 0.80–1.56), while at 2 µg/g creatinine of cadmium excretion the summary risk
ratio was 0.89 (95% confidence interval 0.38–2.14). Analysis restricted to post-menopausal women showed no
association between either dietary or urinary cadmium and subsequent breast cancer incidence and mortality.
Limitations and conclusions: Overall, we found scant evidence of a positive association between cadmium and
breast cancer. Available data were too limited to carry out stratified analyses according to age, smoking and
hormone receptor status. Therefore, possible associations between cadmium exposure and breast cancer in se-
lected subgroups cannot be entirely ruled out.
1. Introduction
Cadmium is a heavy metal toxic for humans with both natural and
anthropogenic sources (ATSDR, 2012). In subjects not occupationally
exposed, diet and smoking are the main sources of exposure (ATSDR,
2012; Filippini et al., 2018). In particular, higher levels of cadmium
may occur in women due to increased absorption in relation to low
levels of iron, and in older subjects due to accumulation of cadmium,
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particularly in liver and kidney (Berglund et al., 1994; Filippini et al.,
2020; Jarup et al., 1983). Cadmium has been associated with increased
risk of chronic diseases including cancer (Akesson et al., 2014; Filippini
et al., 2019b; Satarug et al., 2017b; Tinkov et al., 2017; Tinkov et al.,
2018). The International Agency for Research on Cancer classified
cadmium as carcinogenic to humans (Group I) due to its capacity to
increase risk of lung cancer, and possibly kidney and prostate cancer
(IARC, 2012). Cadmium has also been suspected to increase the risk of
several other cancers, including gynecologic ones (Adams et al., 2014;
McElroy and Hunter, 2019; Vu et al., 2019). The latter association is
made plausible by the estrogen-like properties exhibited by this metal
(Ali et al., 2012; Ali et al., 2016; Kluxen et al., 2013), along with other
mechanisms, including increased migration and epithelial-mesench-
ymal transition of breast cancer cell (Shan et al., 2018; Wang et al.,
2019; Wei et al., 2018). In addition, cadmium has been associated with
genotoxic effects through the production of reactive oxygen species
(ROS), and with epigenetic alterations including DNA methylation and
histone modification, leading to reduction of the antioxidative defense
in breast cells (Cannino et al., 2008; Luevano and Damodaran, 2014).
The possibility that cadmium exposure may increase the risk of breast
cancer has been extensively investigated through recent epidemiolo-
gical studies based on very different indicators of exposure, although
with inconsistent results (Amadou et al., 2020; Gaudet et al., 2019;
Grioni et al., 2019; Jablonska et al., 2017; Jouybari et al., 2018; Larsson
et al., 2015; O'Brien et al., 2019; Strumylaite et al., 2019; Van Maele-
Fabry et al., 2016; White et al., 2019a). These studies have been het-
erogeneous with reference to study design, indicators of cadmium ex-
posure and outcome (incidence or mortality from breast cancer overall
considered, or in relation to specific subtypes). Most epidemiological
studies have based exposure assessment on dietary evaluation of cad-
mium intake or on urinary excretion of the heavy metal, which is the
most reliable biomarker of exposure (Akesson et al., 2014; Satarug
et al., 2017a). Case-control studies assessing this possible relationship
have also been challenged for methodological reasons, since the dis-
ease-related metabolic alterations and an impairment in nutritional
status may lead to changes in circulating levels of trace elements, in-
cluding cadmium (Jablonska et al., 2017; Zaroukian et al., 2005), thus
raising the issue of reverse causation.
Due to lack of dose-response meta-analyses of cohort studies as-
sessing the relation between cadmium exposure and breast cancer, and
the recent availability of advanced biostatistical techniques which are
being tested in risk assessment provided that enough studies with ca-
tegory-specific risk estimates are available (Adani et al., 2020; Crippa
et al., 2019; Filippini et al., 2019a; Larsson and Orsini, 2018; Lugo
et al., 2018; Vinceti et al., 2018), we carried out a dose-response meta-
analysis to investigate the shape of the relation between dietary and
urinary cadmium exposure with breast cancer incidence and mortality
in prospective cohort studies.
2. Methods
2.1. Literature search
We performed online literature searches in the PubMed, Embase
and Web of Science databases until 14 April 2020. The research ques-
tion was configured according to PECOS statement (Population,
Exposure, Comparator(s), Outcomes, and Study design - “Is cadmium
exposure positively associated with female breast cancer incidence and
mortality in prospective cohort studies, also taking into account the
different levels of exposure?”) (Morgan et al., 2018), by using search
terms related to “cadmium” and “breast cancer”. Details about the
search terms are reported in Supplemental Table S1. Reference lists
were further screened to identify additional literature, with the appli-
cation of citation chasing techniques including reference list scanning
of included studies and of previous reviews, as well as backward and
forward citations of included studies (Booth, 2008; European network
for Health Technology Assessment (EUnetHTA) 2017).
A study was considered eligible if: (1) exposure to cadmium was
assessed through a long term indicator of exposure, i.e. assessment of
dietary intake or urinary levels (Akesson et al., 2014; Nawrot et al.,
2010); (2) the outcome of interest was breast cancer incidence and
mortality; (3) it was a prospective cohort, case-cohort or nested case-
control study with a minimum one-year follow-up; (4) risk estimates
were provided using incident rate ratio (IRR), hazard ratio (HR), rate/
risk ratio (RR) or odds ratio (OR), along with the corresponding 95%
confidence interval (CI); and (5) effect estimates were reported for all
exposure categories (either based on fixed cutpoint or percentiles), and
not for some of them only, or for continuous exposure. Case-control
studies with controls not recruited from the same cohort that generated
the breast cancer cases, cross-sectional and animal studies were not
considered. The studies were imported into Covidence systematic re-
view software (Veritas Health Innovation, Melbourne, Australia; www.
covidence.org). At least two authors reviewed all titles and abstracts
independently. When there was disagreement between two authors, a
final decision was reached through the intervention of a third author.
No language restriction was applied to the search strategy.
2.2. Risk of bias assessment
The quality of the included studies was assessed independently by
all authors from the University of Modena and Reggio Emilia, the
University of Athens, and the University of Porto, using the preliminary
Risk of Bias (RoB) in Non-randomized Studies of Exposures (ROBINS-E)
tool (Morgan et al., 2019). Seven domains were covered including: (1)
bias due to confounding; (2) bias in selecting participants in the study;
(3) bias in exposure classification; (4) bias due to departures from in-
tended exposures; (5) bias due to missing data; (6) bias in outcome
measurement; (7) bias in the selection of reported results. Each domain
was characterized as low, moderate, serious or critical risk of bias. We
report in Supplemental Table S2 the criteria for risk of bias evaluation.
In case of disagreement between assessors, we assigned the rate which
obtained the majority of the approvals.
2.3. Data extraction
The following data were extracted by two independent researchers
(MIK, TF) and checked by a third author (CC) for each eligible study:
(1) first author name; (2) publication year; (3) location; (4) duration of
follow‐up; (5) exposure of interest (dietary intake or urinary excretion
of cadmium); (6) recruitment period; (7) date of outcome assessment;
(8) information about the outcome of interest (breast cancer incidence
and mortality); (9) cut-off values for each category of exposure; (10)
number of cases; (11) sample size; (12) adjustment variables in multi-
variable analysis; (13) risk estimates with 95% CIs from the most ad-
justed model.
2.4. Data analysis
We performed a meta-analysis based on categorical exposure to
cadmium, i.e. to the RRs from each study obtained by comparing the
highest versus the lowest exposure category. When more than one study
was carried out on the same cohort and used the same biomarker, we
included in the analysis only the latest report. We applied a random
effects model (DerSimonian and Laird, 1986), and we assessed het-
erogeneity using the I2 statistic (Higgins et al., 2003).
We used the methodology established by Greenland and Longnecker
(1992) and recently developed by Orsini et al. (2012) and Crippa et al.
(2019) to explore the shape of the relation between exposure to cad-
mium and breast cancer, stratifying for exposure assessment method
(reported dietary intake vs urinary excretion). For each exposure ca-
tegory, we extracted the mean or the median depending on the avail-
ability of the data provided by the authors. In cases where this
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information was missing, we used the midpoint of each exposure strata.
When the highest and lowest exposure categories were ‘open’, we used
as boundary a value that was 20% and 15% higher or lower than the
closest cutpoint. In order to investigate the association between ex-
posure and the outcome of interest, we applied the one-stage approach
for dose-response meta-analysis (Crippa et al., 2019; Orsini et al.,
2012). We used a restricted cubic spline model with 3 knots at fixed
percentiles (10, 50, and 90%) of the overall distribution of the dose
according to Harrell’s method (Harrell, 2001), and using a generalized
least-squares regression taking into account the correlation within each
set of published effect estimates (Crippa et al., 2019; Orsini et al.,
2012). Furthermore, we pooled study-specific estimates using the re-
stricted maximum likelihood method in a random-effects meta-analysis
(Jackson et al., 2010; Orsini et al., 2006; Orsini et al., 2012). We also
carried out a stratified analysis according to women’s menopausal
status.
We checked for the possible presence of publication bias using
funnel plots for studies reporting highest versus lowest exposure. In
sensitivity analyses, we used an alternative estimate (i.e. 15% instead of
20%) for the highest and lowest exposure categories with unknown
mean/median values. We provided a graphical overlay of study-specific
predicted curves including fixed and random effects showing the in-
fluence of variation across studies (Crippa et al., 2019), and we assessed
the presence of a linear trend (Orsini et al., 2012). We used Stata 16.1
software (Stata Corp. TX, 2019) for all data analyses, and specifically
the ‘metan’ and ‘metafunnel’ routines for highest versus lowest meta-
analysis and ‘mkspline’, and ‘drmeta’ routines for the dose-response
analysis.
We evaluated the overall certainty of the evidence according to the
GRADE approach (Atkins et al., 2004), which takes in account issues
related to both internal validity (risk of bias, inconsistency, impreci-
sion, publication bias) and external validity such as directness of the
results. We used the GRADEPro GDT (https://gradepro.org) to present a
certainty assessment and summary of findings table. Finally, our review
was implemented using the Preferred Reporting Items for Systematic
Reviews and Meta-Analysis (PRISMA) statement checklist (Moher et al.,
2011) reported in Supplemental Table S3.
3. Results
The PRISMA flow-chart of the literature search is presented in
Fig. 1. We retrieved 752 unique studies, from which 718 were excluded
after title and abstract screening, leaving 34 studies for full-text as-
sessment. Based on full-text evaluation, we additionally excluded 24
studies, including one study (Adams et al., 2012b) carried out on the
same population of one subsequently published study (Lin et al., 2013)
we included in the review. Details of reasons for exclusion are reported
in Fig. 1: excluded studies either did not employ a cohort design, or
they solely provided information of possible mechanisms. Otherwise,
they were reviews or conference abstracts of subsequent included stu-
dies. Finally, for lack of compliance with the study protocol we ex-
cluded the only one study assessing blood cadmium levels (Gaudet
et al., 2019) and the four studies using environmental air cadmium for
exposure assessment: one reporting correlations between air emissions
and incidence of breast cancer across US states (Vu et al., 2019), one
study not reporting cadmium levels across increasing categories of ex-
posure (White et al., 2019a), and the remaining two studies im-
plementing different and non-comparable assessment methods, namely
non-cumulative (Liu et al., 2015) and cumulative cadmium exposure
(Amadou et al., 2020).
Table 1 presents details about the characteristics of the eligible
studies which we eventually considered in the dose-response meta-
analysis. Five studies were conducted in the US (Adams et al., 2012a;
Adams et al., 2014; Adams et al., 2016; Garcia-Esquinas et al., 2014; Lin
et al., 2013), four in Europe (Eriksen et al., 2014; Eriksen et al., 2017;
Grioni et al., 2019; Julin et al., 2012) and one in Japan (Sawada et al.,
2012). We included four studies assessing cadmium exposure using
urine levels (Adams et al., 2016; Eriksen et al., 2017; Garcia-Esquinas
et al., 2014; Lin et al., 2013), and six using dietary intake (Adams et al.,
2012a; Adams et al., 2014; Eriksen et al., 2014; Grioni et al., 2019;
Julin et al., 2012; Sawada et al., 2012). Eight studies assessed breast
cancer incidence (Adams et al., 2012a; Adams et al., 2014; Adams et al.,
2016; Eriksen et al., 2014; Eriksen et al., 2017; Grioni et al., 2019; Julin
et al., 2012; Sawada et al., 2012), and two mortality (Garcia-Esquinas
et al., 2014; Lin et al., 2013).
Detailed and summary RoB assessment with single-item evaluation
and overall study-level risk of bias is reported in Supplemental Tables
S4 and S5. Overall, none of the included studies was at high risk of bias.
All studies accounted for age and body mass index (or both height and
weight). All studies but one (Julin et al., 2012) included smoking habits
in the model, although the authors of this single study reported that the
addition of smoking to the multivariable model did not substantially
change estimates. One study did not adjust for the use hormone re-
placement therapy (Grioni et al., 2019). All studies assessing exposure
through urine levels reported creatinine-adjusted values, while all but
one (Eriksen et al., 2014) among studies using dietary intake presented
energy-adjusted estimates and/or included total energy intake in the
multivariable model. Two studies out of four (Garcia-Esquinas et al.,
2014; Lin et al., 2013) using urinary cadmium excretion focused on
breast cancer mortality, while all studies assessing dietary cadmium
intake considered incidence as the outcome.
The meta-analysis comparing the highest versus the lowest exposure
category showed no association of urine cadmium levels with incidence
or mortality for breast cancer (RR = 1.01, 95% CI 0.70–1.47), as well
as little evidence of a positive association with dietary intake
(RR = 1.04, 95% CI 0.90–1.21 – Supplemental Fig. S1). In the dose-
response meta-analysis, only two studies reported a median value for
each exposure categories (Grioni et al., 2019; Sawada et al., 2012). In
all other studies, we entered the mean values in intermediate categories
and a value 20% higher or lower than the closest cutpoints in open
boundaries. In the analysis considering all women independently from
menopausal status (Fig. 2), we detected a null association between in-
cidence and mortality for breast cancer and urinary cadmium
(RR = 0.96, 95% CI 0.57–1.59, at 1 µg/g creatinine and 0.89, 95% CI
0.37–2.14 at 2 µg/g creatinine). Conversely, we found a marginal and
statistically imprecise positive association between dietary cadmium
and breast cancer (RR = 1.04, 95% CI 0.81–1.33 at 10 µg/day, and
1.12, 95% CI 0.80–1.56 at 20 µg/day).
In the dose-response meta-analysis restricted to post-menopausal
women only, there was little evidence of any association between ex-
posure and breast cancer either using dietary assessment methods or
urinary excretion (Fig. 3). Conversely, the comparison of the highest
versus lowest category in this subgroup indicated no association based
on dietary cadmium, and a weak positive association based on urinary
cadmium excretion (Supplemental Fig. S2). The analysis restricted to
pre-menopausal women could only include two studies assessing
dietary cadmium intake, fewer than the number needed for a dose-re-
sponse spline regression analysis, but enough for a meta-analysis
comparing extreme exposure categories. The latter analysis showed
little association between exposure and breast cancer incidence
(RR = 1.12, 95% CI 0.44–2.87 – Supplemental Fig. S3), based on op-
posite results in the two studies. For urinary cadmium, stratified ana-
lysis based on outcome assessment (incidence vs. mortality) showed
limited evidence of any difference between the two outcomes, despite a
slightly higher risk ratio for the latter (RR = 0.96, 95% CI 0.68–1.36;
RR = 1.18, 95% CI 0.32–4.33, respectively – Supplemental Fig. S4). In
a sensitivity analysis entering a±15% value instead of 20% for open
boundaries in exposure categories, we found comparable results
(Supplemental Fig. S5).
We also reported study-specific dose-response relations from leave-
one-out analysis in addition to the overall dose-response meta-analyses,
which were particularly heterogeneous for estimates based on dietary
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cadmium (Supplemental Fig. S6). Linear regression analysis of the re-
lation between cadmium exposure and breast cancer showed a sub-
stantially comparable pattern compared with the overall spline analysis
(Supplemental Fig. S7).
Funnel plots based on the different exposure assessment methods
showed a substantially symmetric distribution and yielded little evi-
dence of publication bias. Due to the low number of publications,
however, such bias could not be entirely ruled out (Supplemental Fig.
S8).
Finally, the GRADE assessment showed low-certainty of the evi-
dence for an enhanced breast cancer incidence and mortality induced
by both dietary and urinary cadmium exposure, due to directness of the
exposure assessment based on cadmium evaluation, a generally im-
precise effect due to the width of 95% confidence interval, lack of
serious risk of bias, no substantial publication bias, and the presence of
a moderate/serious inconsistency of results, an imprecise and not large
effect with no dose-response gradient (Table 2).
4. Discussion
Overall, we did not find evidence to link higher cadmium exposure
to an enhanced incidence and mortality for breast cancer, both in di-
chotomous, traditional meta-analysis and in dose-response spline re-
gression meta-analysis. In the latter, we found some though very im-
precise evidence of a weak positive association for the highest dietary
cadmium intake (above 20 µg/day approximately). However, this
finding was not replicated by the analysis based on the biomarker, that
is cadmium urinary excretion. This indicator had a major advantage: it
took into account all sources of exposure, including active and passive
smoking and more generally air pollution, as well as long-term and slow
cadmium release by organs such as the kidneys (Akesson et al., 2014;
Satarug et al., 2017a). Therefore, estimates based on dietary intake
assessment could have been biased by methodological limitations in the
evaluation of exposure including exposure misclassification due to
changes of dietary habits over time. In fact, these studies considered
exposure at a single point in time, which cannot probably reflect ex-
posure variation over a long period of time (Filippini et al., 2016;
Satarug et al., 2017a), and in addition they could have suffered from
residual, unmeasured confounding. An alternative hypothesis is that a
positive association actually existed between cadmium dietary intake
and cancer risk, but that such association is no longer detectable when
exposure assessment is based on a biomarker such as urinary cadmium,
either for limitations of the biomarker or for residual confounding.
However, urinary cadmium is considered to be a reliable biomarker of
exposure to this heavy metal (Akesson et al., 2014; Satarug et al.,
2017a). Also, generally high correlation is found between urinary
cadmium levels in samples collected in the same subjects 4–6 years
apart (Meliker et al., 2019). Nonetheless, we cannot entirely rule out
that factors such as changes in smoking habits or occurrence of diseases
characterized by increased excretion of proteins may produce short-
term changes in urinary cadmium levels, thus influencing exposure
assessment based on urinary cadmium excretion (Vacchi-Suzzi et al.,
2016).
The absence of evidence for an association between overall cad-
mium exposure and breast cancer was even stronger when we limited
the analysis to studies in post-menopausal women only. This is in
keeping with the hypothesis that breast cancer risk factors or effect
modification by age could differ according to age of disease onset or
Fig. 1. Flow-chart of systematic literature search on cadmium exposure and breast cancer until 14 April 2020.
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5
menopausal status (Strumylaite et al., 2010). In such a subgroup, in
fact, dietary cadmium also showed little association with breast cancer.
Conversely, we could not carry out a specific analysis for pre-meno-
pausal women due to a lack of data for the latter. However, the di-
chotomous meta-analysis based on the comparison of extreme cate-
gories of exposure for pre-menopausal women did not yield results
suggestive of an association in this subgroup as well.
The substantial lack of association between cadmium exposure and
breast cancer incidence and mortality we detected in this dose-response
meta-analysis is not entirely surprising, given the most recent results of
other studies testing this association based on exposure assessment with
blood or air cadmium levels (Amadou et al., 2020; Gaudet et al., 2019;
Liu et al., 2015; Vu et al., 2019; White et al., 2019b). In particular, the
only study on breast cancer that assessed cadmium exposure using
blood levels drawn from three different cohorts (Gaudet et al., 2019)
found an inverse association RR = 0.59 (95% CI 0.39–0.91) when
comparing the highest versus the lowest exposure category. In addition,
despite some biological plausibility of such association based on some
toxic properties of the heavy metal, such as estrogenicity, reactive
oxygen species production and DNA damage (Akesson et al., 2014),
other studies highlighted cadmium properties compatible with even a
reduced risk of breast cancer. Such effects are cadmium-induced lower
estradiol levels or adverse effects of the metal on angiogenesis and cell
viability, properties which might explain recently reported inverse as-
sociations between cadmium exposure and breast cancer (Amadou
et al., 2020; Gaudet et al., 2019).
Because of the lack of data, we could not assess using dose-response
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Fig. 2. Dose-response meta-analysis between cadmium exposure and breast
cancer using dietary intake – dCd (A) or urine levels – uCd (B) in all women.
Spline curve (solid line) with 95% confidence limits (dashed lines). RR: risk
ratio.
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meta-analysis the role of confounding factors such as body mass index
and smoking habits or whether cadmium exposure may play a role in
the induction of specific breast cancer subtypes based on hormone re-
ceptor status. This is particularly so if cancer subtypes are rare enough
compared with the remaining disease forms and therefore unable to
modify the overall shape of the relation. Some studies suggested that
the hormone receptor status of breast cancer may modify the associa-
tion, although other reports found little support for this (Amadou et al.,
2020; Grioni et al., 2019; Julin et al., 2012; Van Maele-Fabry et al.,
2016). In addition, our meta-analysis included studies assessing both
breast cancer incidence and mortality and this may have introduced
some heterogeneity in the summary risk estimates, since different
etiological factors may be implicated in the onset of or the death from
breast cancer.
We consider the dose-response modelling of the association between
cadmium exposure and breast cancer incidence and mortality as main
strength of this review. To the best of our knowledge, this was per-
formed only once, based on urinary cadmium excretion only and on a
smaller number of studies compared with those we could retrieve
(Larsson et al., 2015). Conversely, we must acknowledge some het-
erogeneity among the included studies: this includes the use of mor-
tality as a surrogate for incidence in two of the four studies based on
urinary cadmium. Unfortunately, only two studies investigated the as-
sociation between urinary cadmium excretion and breast cancer in-
cidence, hampering us from carrying out the dose-response analysis
excluding breast cancer mortality. Also, the higher heterogeneity may
be due to different menopausal status of studies populations. However,
Fig. 3. Dose-response meta-analysis between cadmium exposure and breast
cancer using dietary intake – dCd (A) or urine levels –uCd (B) in post-meno-
pausal women. Spline curve (solid line) with 95% confidence limits (dashed
lines). RR: risk ratio.
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the subgroup analysis suggested no major effects of this potential source
of heterogeneity on the summary risk estimates, while such estimates
were statistically too unstable to rule out slightly positive associations.
Another limitation of our assessment may derive from the inclusion of
vegetable consumption in the potential confounders adjusted for some
studies based on dietary cadmium assessment (Adams et al., 2012a;
Adams et al., 2014; Grioni et al., 2019; Sawada et al., 2012), and of
smoking in all studies based on urinary cadmium. These two are the
most important sources of cadmium exposure in non-occupationally
exposed individuals (ATSDR, 2012; Filippini et al., 2018; IARC, 2012).
Therefore, adjustment for these factors, despite improving confounding
control, may have led to overadjustment by decreasing the gradient in
exposure, thus contributing to the lack of detection of any relation
between exposure and risk in both the single studies and our meta-
analysis. Unfortunately, risk estimates stratified by smoking or vege-
table intake were not available in sufficient numbers to carry out dose-
response meta-analyses in selected subgroups, such as non-smokers or
smokers. However, there was some sparse evidence of possible relations
in such subgroups in single studies, such as the increased breast cancer
risk found in smokers with the highest urinary cadmium levels but not
in never-smokers in the study by Eriksen et al. (Eriksen et al., 2017),
suggesting the need to further investigate this issue. We cannot also rule
out that some non-differential exposure misclassification may have
occurred, likely biasing the risk estimates towards the null and ham-
pering the detection of any possible weak association between cadmium
and breast cancer. We also note that several case-control studies have
reported increased odds of breast cancer in women with the highest
cadmium exposure as compared to those in the lowest exposure cate-
gories (Gallagher et al., 2010; Itoh et al., 2014; McElroy et al., 2006;
Nagata et al., 2013; Strumylaite et al., 2019). This study design is
however hampered by sources of bias, including (but not limited to)
reverse causation due to dietary changes in patients or disease-induced
changes in cadmium metabolism.
5. Conclusions
Overall, we found no relation between the investigated levels of
cadmium exposure and breast cancer incidence and mortality.
Nevertheless, due to the lack of enough data on smoking and hormone
receptor status to carry out stratified analyses, possible associations
between cadmium exposure and breast cancer in selected subgroups
cannot be entirely ruled out.
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